[EN] NOVEL ANTI-VIRAL AGENTS BASED UPON DERIVATIVES OF THE AROMATIC HETEROCYCLE PHENANTHRIDINE<br/>[FR] NOUVEAUX AGENTS ANTIVIRAUX FORMES A PARTIR DE DERIVES DE L'HETEROCYCLE AROMATIQUE PHENANTHRIDINE
申请人:UNIV CALIFORNIA
公开号:WO2005016343A1
公开(公告)日:2005-02-24
A series of substituted phenanthridine derivatives has been synthesized by converting the amines at the 3- and 8- positions of ethidium bromide into guanidine, pyrrole, urea, and various substituted ureas. The resulting derivatives exhibit unique spectral properties that change upon binding nucleic acids. The compounds have an enhanced affinity and specificity for HIV-1 Rev Response Element as compared to ethidium bromide.
CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
申请人:Samsung Display Co., Ltd.
公开号:US20190031614A1
公开(公告)日:2019-01-31
A condensed cyclic compound and an organic light-emitting device including the same are disclosed. According to an embodiment of the present disclosure, a condensed cyclic compound is represented by Formula 1:
N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of C-proteinase and for treating or preventing disorders related to unregulated collagen production
申请人:——
公开号:US20030191309A1
公开(公告)日:2003-10-09
The present invention relates to a novel class of organic molecules capable of inhibiting C-proteinase, and to their use to regulate, modulate and/or inhibit abnormal collagen formation as a therapeutic approach towards the treatment of fibrotic disorders.
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
申请人:Kozikowski P. Alan
公开号:US20070161640A1
公开(公告)日:2007-07-12
The present invention provides 4-substituted-2-azetidinone compounds, bicyclic 2-5-diketopiperazine compounds, and pharmaceutical compositions thereof that are potent, safe and effective neuroprotective agents. Due to their strong central nervous system (CNS) activity, the compounds can be used to enhance memory and to treat a variety of neurological disorders. The compounds are particularly useful for treating neurological disorders caused by, or associated with, CNS trauma.
NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME
申请人:Murakami Masahiro
公开号:US20110046372A1
公开(公告)日:2011-02-24
The present invention provides novel boron compounds which are useful, depending on their characteristics, as light-emitting materials, electron-transport materials, electron-injection materials, hole-blocking materials, or organic semiconductor materials, and which have new molecular structures quite different from those of the heretofore known boron compounds; their production processes; and functional electronic devices using the same. The novel boron compounds are, for example, those of the following formula (1):
These boron compounds can be produced by, for example, reacting boron compounds of the following formula (4):
with compounds of the following formula (5):
in the presence of a catalyst containing at least one metal element selected from the group consisting of palladium, platinum, and nickel. These boron compounds are used for the functional electronic devices.